Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,810.06
(
-0.11%
)
News Focus
News Focus

Replies to post #456 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #456 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

06/19/14 4:00 PM

#457 RE: linhdtu #456

ABBV/ENTA’s Japanese phase-3 trials will be completed in Nov 2014 and Dec 2014, respectively, for GT1b and GT2 patients: #msg-95444387.